Drug
Blu 222
Blu 222: highest development phase Phase 1, developed by Blueprint Medicines. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Blueprint Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| BLU-222 NCT05252416 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Blu 222 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.